A new study found that, in the TME, the angiogenic factor VEGF-α mainly exists in T3 neutrophil subsets, and its activation may promote tumor angiogenesis, indicating that T3 neutrophils may be a new target for pathological angiogenesis in tumors [128]. This evidence concerns the gene VEGFA and neoplasm.